BITS Pilani will start accepting online applications for BITSAT 2026 today for admission to its undergraduate engineering, BPharm and MSc programmes.
France: A phase 1 double-blind controlled study reported in Nature Communications has shown that vaccine immunotherapy targeting interleukin-6 (IL-6) is safe and produces a strong anti-IL-6 immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback